2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Interleukin-22: immunobiology and pathology

JA Dudakov, AM Hanash… - Annual review of …, 2015 - annualreviews.org
Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T
helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs) …

Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up

BP Alter, N Giri, SA Savage, PS Rosenberg - Haematologica, 2017 - pmc.ncbi.nlm.nih.gov
The National Cancer Institute Inherited Bone Marrow Failure Syndromes Cohort enrolls
patients with the four major syndromes: Fanconi anemia, dyskeratosis congenita, Diamond …

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2009 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

[PDF][PDF] Thyroid nodules: diagnosis and management

R Wong, SG Farrell, M Grossmann - Medical Journal of Australia, 2018 - mja.com.au
Thyroid nodules: diagnosis and management Page 1 Thyroid nodules: diagnosis and
management Rosemary Wong1, Stephen G Farrell2,3, Mathis Grossmann2,4 Thyroid nodules …

Hematopoietic stem-cell transplantation

EA Copelan - New England Journal of Medicine, 2006 - Mass Medical Soc
Hematopoietic stem-cell transplantation, which is used to treat both malignant and
nonmalignant conditions, was first conceived more than 50 years ago, but problems …

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation

JR Wingard, NS Majhail, R Brazauskas… - Journal of clinical …, 2011 - ascopubs.org
Purpose Allogeneic hematopoietic cell transplantation (HCT) is curative but is associated
with life-threatening complications. Most deaths occur within the first 2 years after …

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2006 - liebertpub.com
THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

Palliative and end-of-life care for patients with hematologic malignancies

A El-Jawahri, AM Nelson, TF Gray, SJ Lee… - Journal of Clinical …, 2020 - ascopubs.org
Hematologic malignancies are a heterogeneous group of diseases with unique illness
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

JJ Cornelissen, A Gratwohl, RF Schlenk… - Nature reviews Clinical …, 2012 - nature.com
Allogeneic haematopoietic stem-cell transplantation (HSCT) is frequently applied as part of
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …